(Health-NewsWire.Net, October 10, 2016 ) Publisher's, 'Tankyrase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 5 or Poly [ADP Ribose] Polymerase 5A or TRF1 Interacting Ankyrin Related ADP Ribose Polymerase or TNKS or EC 2.4.2.30) - Pipeline Review, H2 2016', provides in depth analysis on Tankyrase...
(Health-NewsWire.Net, October 10, 2016 ) Publisher's, 'Smoothened Homolog (Protein Gx or SMO) - Pipeline Review, H1 2016', provides in depth analysis on Smoothened Homolog (Protein Gx or SMO) targeted pipeline therapeutics. The report provides comprehensive information on the Smoothened Homolog (Protein...
(Health-NewsWire.Net, October 10, 2016 ) Report SummaryPublisher's, 'Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia And Rad3 Related Protein or FRAP Related Protein 1 or ATR or EC 2.7.11.1) - Pipeline Review, H2 2016', provides in depth analysis on Serine/Threonine Protein Kinase ATR...
(Health-NewsWire.Net, October 10, 2016 ) Publisher's, 'Rheumatoid Arthritis - Pipeline Review, H1 2016', provides an overview of the Rheumatoid Arthritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rheumatoid Arthritis, complete with...
(Health-NewsWire.Net, October 10, 2016 ) Publisher's, 'Psoriasis - Pipeline Review, H1 2016', provides an overview of the Psoriasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with analysis by stage of development,...
(Health-NewsWire.Net, October 10, 2016 ) Publisher's, 'Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Pipeline Review, H2 2016', provides in depth analysis on Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3...
(Health-NewsWire.Net, October 10, 2016 ) Publisher's, 'Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha Polypeptide or Serine/Threonine Protein...
(Health-NewsWire.Net, October 10, 2016 ) SummaryPublisher's, 'Peroxisome Proliferator-Activated Receptor Delta (PPAR-Delta or NUCI or Nuclear Hormone Receptor 1 or NUC1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator-Activated Receptor Beta or PPAR-Beta or PPARD or NR1C2)...
(Health-NewsWire.Net, October 10, 2016 ) Report SummaryPublisher's, 'Peptidyl Prolyl Cis Trans Isomerase D (40 kDa Peptidyl Prolyl Cis Trans Isomerase or Cyclophilin 40 or Cyclophilin D or Rotamase D or PPID or EC 5.2.1.8) - Pipeline Review, H2 2016', provides in depth analysis on Peptidyl Prolyl...
(Health-NewsWire.Net, October 10, 2016 ) Report SummaryPublisher's, 'P27 (Negative Regulatory Factor or Nef) - Pipeline Review, H2 2016', provides in depth analysis on P27 (Negative Regulatory Factor or Nef) targeted pipeline therapeutics. The report provides comprehensive information on the P27...
(Health-NewsWire.Net, October 10, 2016 ) Publisher's, 'Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) - Pipeline Review, H2 2016', provides in depth analysis on Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid...
(Health-NewsWire.Net, October 10, 2016 ) Publisher's, 'Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Pipeline Review, H2 2016', provides in depth analysis on Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) targeted pipeline therapeutics. The report provides comprehensive information...
(Health-NewsWire.Net, October 10, 2016 ) Publisher's, 'Mycobacterium tuberculosis Protein Ag85A - Pipeline Review, H2 2016', provides in depth analysis on Mycobacterium tuberculosis Protein Ag85A targeted pipeline therapeutics. The report provides comprehensive information on the Mycobacterium tuberculosis...
(Health-NewsWire.Net, October 10, 2016 ) Publisher's, 'Multiple Sclerosis - Pipeline Review, H1 2016', provides an overview of the Multiple Sclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Multiple Sclerosis, complete with analysis...
(Health-NewsWire.Net, October 11, 2016 ) Publisher's, 'Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016', provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Multiple...
|